Fig. 7From: Inhibition of mitochondrial carrier homolog 2 (MTCH2) suppresses tumor invasion and enhances sensitivity to temozolomide in malignant gliomaModel. A schematic demonstrates that MTCH2 regulates cell invasion/apoptosis of malignant gliomas. Silencing of MTCH2 expression impairs cell migration via F-actin depolymerization, decreases cell invasion via MMP-9 pathway, and represses pro-survival AKT signaling to promote TMZ-induced cell deathBack to article page